loaderimg
image

LymphaTouch Inc. is a pioneering Finnish healthcare technology company developing treatment device based on negative pressure. LymphaTouch Inc. was originally developed in 2005. The first device was developed for physiotherapy and rehabilitation professionals to support lymphedema treatment.

Our LymphaTouch device, previously also known as PhysioTouch, has been successfully used among physiotherapy, lymph therapy and rehabilitation, to help treating swelling and edema, and promoting faster recovery for patients. LymphaTouch is already used worldwide.

The goal of our company is to promote treatment that is based on scientific evidence, and benefits patients, caregivers and the healthcare society.

Our Mission
Create innovative therapeutic solutions to improve patient lives

Our Vision
Leading manufacturer of professional therapeutic devices for oncology, orthopaedic, sports, neurology, and MSD

Our values are:
• Integrity – we run our business with honesty and high integrity
• Passion – we simply love what we do
• Happiness – we create positive and inspiring environment
• Commitment – we are committed to high quality and customer focus
• Growth – we grow profitably and encourage individual development

LymphaTouch Inc. is ISO 9001:2008 and ISO 13485:2003 certified. Our products are manufactured in Finland and are CE marked in accordance with directive 93/42/EEC. LymphaTouch is also FDA Class 1 Exempt device.

Company’s Keywords:

lymphedema treatment, physiotherapy devices, reduced swelling & pain, improved range of motion, fast patient recovery, rehabilitation, occupationatherapy, sports, medicaldevicesales

Q How Many Employees Does This Company Have?

<11

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2005

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image